Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADMSC Injection for Premature Ovarian Failure
NCT02603744Phase 2Unknown
- Sponsor
- Royan Institute
- Start
- Jun 2015
- Primary completion
- Jun 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of adipose derived mesenchymal stromal cells in primary ovarian insufficiency (POI), sponsored by Royan Institute. Status: unknown.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT02603744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02603744.